高级检索
当前位置: 首页 > 详情页

LncRNA MALAT1 induces the dysfunction of beta cells via reducing the histone acetylation of the PDX-1 promoter in type 1 diabetes

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Hosp 4, Dept Endocrinol, 12 Jiankang Rd, Shijiazhuang 050000, Hebei, Peoples R China [2]Hebei Med Univ, Hosp 4, Dept Pain Rehabil, Shijiazhuang, Hebei, Peoples R China
出处:
ISSN:

关键词: beta cell Insulin MALAT1 PDX-1 Histone acetylation

摘要:
Background: Type 1 diabetes (T1DM) severely threatens human health, and the dysfunction of insulin-secreting beta cells in islets is related to the reduced PDX-1 expression. It has been reported that long non-coding RNA MALAT1 regulates beta cell function, while the potential mechanism is unclear. Methods: Islets were isolated from non-obese diabetic (NOD) mice and wild type (WT) mice. Mouse islets and beta cell line (Min6) were stimulated by IL-1 beta. The expression of MALAT1 was determined using real-time PCR, while the PDX-1 protein expression was determined using western blotting. ChIP-qPCR was carried out to determine the histone acetylation of the PDX-1 promoter. Results: In NOD islets and IL-1 beta-stimulated Min6 cells, the expression of MALAT1 was increased, while the mRNA and protein levels of PDX-1 were decreased at an age/time-dependent manner. Overexpressing MALAT1 suppressed the H3 histone acetylation of the PDX-1 promoter, inhibiting both mRNA and protein expressions of PDX-1. Knocking down MALAT1 restored the decrease of the histone acetylation of the PDX-1 promoter, as well as the PDX-1 expression, which was reduced by IL-1 beta stimulation. Under high glucose stimulation, the overexpression of PDX-1 alone restored the insulin secretion which was inhibited by the simultaneous overexpression of MALAT1 and PDX-1. Under high glucose and IL-1 beta stimulation, the simultaneous knockdown of MALAT1 and PDX-1 reduced the enhancement of the insulin secretion which was raised by knocking down MALAT1 alone. Conclusion: MALAT1 induces the dysfunction of beta cells via reducing the H3 histone acetylation of the PDX-1 promoter and subsequently inhibiting the expression of PDX-1, thus suppressing the insulin secretion.

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 病理学
最新[2025]版:
大类 | 4 区 医学
小类 | 3 区 病理学
JCR分区:
出版当年[2020]版:
Q2 PATHOLOGY
最新[2023]版:
Q2 PATHOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Hosp 4, Dept Endocrinol, 12 Jiankang Rd, Shijiazhuang 050000, Hebei, Peoples R China
通讯作者:
通讯机构: [1]Hebei Med Univ, Hosp 4, Dept Endocrinol, 12 Jiankang Rd, Shijiazhuang 050000, Hebei, Peoples R China [*1]Department of Endocrinology, The Fourth Hospital of Hebei Medical University, No. 12 Jiankang Road, Shijiazhuang 050000, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号